FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday.
Source: ABC News 6